» Articles » PMID: 30180847

Regional Heterogeneity in Response of Airway Epithelial Cells to Cigarette Smoke

Overview
Journal BMC Pulm Med
Publisher Biomed Central
Specialty Pulmonary Medicine
Date 2018 Sep 6
PMID 30180847
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cigarette smoke (CS) exposure causes an abnormal inflammatory response, which can result in chronic obstructive pulmonary disease (COPD). Previous studies show that this disorder predominantly occurs in peripheral or small-airway areas, whereas the same condition has not been identified in the larger airways during the course of COPD. However, the different biochemical and genetic alterations occurring in response to CS exposure among airway epithelial cells from different sites in the lungs have not been fully investigated.

Methods: Human small airway epithelial cells (SAECs) and normal human bronchial epithelial cells (NHBEs) were exposed to CS extract (CSE), and microarray analysis was used to determine gene- and protein-expression profiles and identify alterations following CSE exposure in both cell types. An in vivo smoking experiment was also performed to confirm differential responses to CS between sites in the lung.

Results: Microarray analysis of SAECs and NHBEs following 24 h of CSE exposure showed that inflammatory related pathways and terms, including the tumor necrosis factor-signaling pathway, were overrepresented, especially in SAECs. Clustering analysis highlighted prostaglandin-endoperoxide synthase-2 [also known as cyclooxygenase (COX)-2] as a gene specifically upregulated in SAECs, with COX-2 mRNA and protein expression significantly elevated by CSE exposure in SAECs (3.1- and 3.1-fold, respectively), but not in NHBEs. Furthermore, time-course analysis of COX-2 expression revealed earlier increases in SAECs compared with NHBEs following CS exposure. Short-term exposure of mouse lungs to CS was found to predominantly induce COX-2 expression in the small airway.

Conclusions: The small airway is more susceptible to CSE than the large airway and could be the initial site of development of CS-related respiratory diseases, such as COPD.

Citing Articles

The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis.

Kotlyarov S Int J Mol Sci. 2023; 24(10).

PMID: 37240069 PMC: 10217854. DOI: 10.3390/ijms24108725.


Propylene glycol, a component of electronic cigarette liquid, damages epithelial cells in human small airways.

Komura M, Sato T, Yoshikawa H, Nitta N, Suzuki Y, Koike K Respir Res. 2022; 23(1):216.

PMID: 35999544 PMC: 9400210. DOI: 10.1186/s12931-022-02142-2.


Reversal of NADPH Oxidase-Dependent Early Oxidative and Inflammatory Responses in Chronic Obstructive Pulmonary Disease by Puerarin.

Zhang P, Zhang Y, Wang L, Wang X, Xu S, Zhai Z Oxid Med Cell Longev. 2022; 2022:5595781.

PMID: 35651727 PMC: 9151001. DOI: 10.1155/2022/5595781.


Imbalanced prostanoid release mediates cigarette smoke-induced human pulmonary artery cell proliferation.

Alqarni A, Brand O, Pasini A, Alahmari M, Alghamdi A, Pang L Respir Res. 2022; 23(1):136.

PMID: 35643499 PMC: 9145181. DOI: 10.1186/s12931-022-02056-z.


Cellular and Molecular Signatures of Oxidative Stress in Bronchial Epithelial Cell Models Injured by Cigarette Smoke Extract.

Cipollina C, Bruno A, Fasola S, Cristaldi M, Patella B, Inguanta R Int J Mol Sci. 2022; 23(3).

PMID: 35163691 PMC: 8836577. DOI: 10.3390/ijms23031770.


References
1.
Sato T, Seyama K, Sato Y, Mori H, Souma S, Akiyoshi T . Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med. 2006; 174(5):530-7. DOI: 10.1164/rccm.200511-1816OC. View

2.
Rennard S, Drummond M . Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet. 2015; 385(9979):1778-1788. PMC: 4819246. DOI: 10.1016/S0140-6736(15)60647-X. View

3.
Battaglia S, Mauad T, van Schadewijk A, Vignola A, Rabe K, Bellia V . Differential distribution of inflammatory cells in large and small airways in smokers. J Clin Pathol. 2006; 60(8):907-11. PMC: 1994511. DOI: 10.1136/jcp.2006.037002. View

4.
Domej W, Oettl K, Renner W . Oxidative stress and free radicals in COPD--implications and relevance for treatment. Int J Chron Obstruct Pulmon Dis. 2014; 9:1207-24. PMC: 4207545. DOI: 10.2147/COPD.S51226. View

5.
Anthonisen N, Connett J, Murray R . Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002; 166(5):675-9. DOI: 10.1164/rccm.2112096. View